Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Clinical trial NCT00258284 · COMPLETED
Trial details
- NCT number
- NCT00258284
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2007-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.